Partial
Partially Aligned
Patient Risk:
Low
Summary
The response accurately identifies muscle pain and weakness as label-supported effects, but the claims about dizziness and lightheadedness are not supported by the supplied prescribing information.
Category Scores
Accurate Statements
Atorvastatin labeling and safety resources include muscle pain and weakness among possible effects.
The supplied label states that atorvastatin may cause myopathy involving muscle aches or muscle weakness, advises reporting unexplained muscle pain, tenderness, or weakness, and lists myalgia as a clinical adverse reaction in Sections 5.1 and 6.1.
Unsupported Statements
Dizziness is a possible side effect of atorvastatin.
Dizziness is not listed or described in the supplied adverse-reaction or skeletal-muscle sections.
People taking atorvastatin may report feeling lightheaded or dizzy.
Lightheadedness and dizziness are not described in the supplied prescribing-information sections.
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The unsupported dizziness claims could misattribute symptoms to atorvastatin, but the response provides no dosing or treatment instructions. The muscle pain and weakness statement is consistent with the label.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
Two of the three adverse-effect claims are not supported by the supplied FDA label sections.
Suggested Improvement
Remove or qualify the dizziness and lightheadedness claims as not established by the supplied label; retain the statement about muscle pain and weakness.